Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing
Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing
Inventiva成功获得2140万欧元，成功完成34800万欧元融资的第一阶段。
- Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024.
- Proceeds from the completed first tranche to be primarily used to advance Inventiva's Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH.
- Appointment of Mark Pruzanski as new Chairman of the Board of Directors and Srinivas Akkaraju as new member of the Board of Directors.
- Inventiva获得2140万欧元，完成了11600万欧元融资的第一部分，这是2024年10月14日宣布的最高34800万欧元多阶段股权融资的一部分。
- 完成的第一阶段所得款项将主要用于推进Inventiva的III期NATiV3临床试验，该试验评估lanifibranor在MASH患者中的疗效。
- 任命Mark Pruzanski为新任董事会主席，Srinivas Akkaraju为新任董事会成员。
资讯热榜
更新时间